BiomX Inc. is projected to rise to $0.2079 by 2027, a +11% move from its current price of $0.1868. PHGE is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.1762 | $0.1868 | $0.1981 | +0.02% |
| Aug 6 | $0.172 | $0.1869 | $0.203 | +0.03% |
| Aug 7 | $0.1689 | $0.1869 | $0.2069 | +0.05% |
| Aug 8 | $0.1663 | $0.1869 | $0.2102 | +0.07% |
| Aug 9 | $0.164 | $0.187 | $0.2131 | +0.08% |
| Aug 10 | $0.162 | $0.187 | $0.2158 | +0.10% |
| Aug 11 | $0.1602 | $0.187 | $0.2184 | +0.12% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.1602 | $0.187 | $0.2184 | +0.12% |
| Week 2 | $0.1504 | $0.1872 | $0.2331 | +0.23% |
| Week 3 | $0.1433 | $0.1875 | $0.2452 | +0.35% |
| Week 4 | $0.1376 | $0.1877 | $0.2559 | +0.47% |
| Week 5 | $0.1329 | $0.1879 | $0.2657 | +0.58% |
| Week 6 | $0.1287 | $0.1881 | $0.275 | +0.70% |
| Week 7 | $0.125 | $0.1883 | $0.2838 | +0.82% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
BiomX Inc. (PHGE) is a holding company in the Industrials sector. Its focus is defense, security, and critical infrastructure technologies, with a portfolio that targets counter-drone systems, AI-enabled command-and-control, perimeter and border security, wide-area surveillance, and aerial firefighting.
It serves defense agencies, prime contractors, transportation operators, municipalities, and critical infrastructure providers.
BiomX was founded in 2015 and is based in Dover, Delaware.
BiomX Inc. is currently priced at $0.189 and has a market cap of $2.04M. It ranks 5200.
In the near term, the technical picture is NEUTRAL, with RSI14 at 30. The SMA50 is $0.5586 and SMA200 is $3.82. Current support is $0.198 and resistance is $0.708. The 30-day price range runs from $0.1217 to $0.2935.
Forecast snapshot shows a year-by-year path. For 2026 min $0.189, avg $0.189, max $0.2937, ROI 0%; 2027 min $0.1532, avg $0.2106, max $0.3129, ROI 11.4%; 2028 min $0.1527, avg $0.2232, max $0.3537, ROI 18.1%; 2029 min $0.1169, avg $0.18, max $0.2996, ROI -4.8%; 2030 min $0.0921, avg $0.1487, max $0.2577, ROI -21.3%; 2031 min $0.13, avg $0.2194, max $0.3937, ROI 16.1%; 2032 min $0.1443, avg $0.2541, max $0.4702, ROI 34.5%; 2033 min $0.1375, avg $0.2521, max $0.4796, ROI 33.4%; 2034 min $0.1381, avg $0.2634, max $0.5137, ROI 39.4%; 2035 min $0.1129, avg $0.2239, max $0.4468, ROI 18.5%; 2040 min $0.1493, avg $0.3317, max $0.7277, ROI 75.5%; 2050 min $0.2933, avg $0.6517, max $1.50, ROI 244.8%.
A major floor 2.0% below — a decisive break under it would weaken the trend.
Price is testing support right now (2.0% away) — a key level to hold.
The nearest ceiling, 178.4% above — a clean break opens room to run.
A major ceiling 2517.8% above — clearing it would confirm fresh momentum.
Key PHGE support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PHGE market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.1872 | Sell | $0.1878 | Sell |
| MA 10 | $0.1936 | Sell | $0.1979 | Sell |
| MA 20 | $0.2193 | Sell | $0.2472 | Sell |
| MA 50 | $0.5167 | Sell | $0.6025 | Sell |
| MA 100 | $1.60 | Sell | $1.53 | Sell |
| MA 200 | $3.50 | Sell | $3.76 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 27.36 | Buy |
| Stoch RSI (14) | 78.46 | Neutral |
| CCI (20) | -76.79 | Neutral |
| Williams %R (14) | -96.43 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | -12.80 | Sell |
| Bollinger %B (20,2) | 0.27 | Neutral |
| Stochastic %K (14) | 3.57 | Buy |
| TRIX (15) | -3.68 | Sell |
| Awesome (5,34) | -0.12 | Sell |
| Ultimate (7,14,28) | 26.02 | Buy |
| Momentum (10) | -0.02 | Sell |
| Aroon Osc (25) | -88.00 | Sell |
| Hull MA (9) | 0.18 | Buy |
| ADX (14) | 42.88 | Sell |
| ATR (14) | 0.02 | Info |
The 30-day technical picture is NEUTRAL. RSI14 is 30, indicating a neutral momentum stance. The stock trades with a 30-day range from $0.1217 to $0.2935, with a nearby support at $0.198 and a resistance at $0.708.
SMA50 sits at $0.5586 and SMA200 sits at $3.82, signaling how recent prices compare to standard trend lines. The overall sentiment from the data remains NEUTRAL in the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.183 | $0.1868 | $0.2898 | 0% | Neutral | |
| $0.1515 | $0.2079 | $0.3083 | +11% | Neutral | |
| $0.1502 | $0.2192 | $0.3469 | +17% | Neutral | |
| $0.1184 | $0.1822 | $0.3029 | -2% | Neutral | |
| $0.0911 | $0.1469 | $0.2543 | -21% | Bearish | |
| $0.1244 | $0.2098 | $0.3761 | +12% | Neutral | |
| $0.145 | $0.255 | $0.4715 | +37% | Bullish | |
| $0.1375 | $0.2518 | $0.4786 | +35% | Bullish | |
| $0.1331 | $0.2536 | $0.4942 | +36% | Bullish | |
| $0.114 | $0.2258 | $0.4505 | +21% | Bullish | |
| $0.1456 | $0.3235 | $0.7095 | +73% | Bullish | |
| $0.2917 | $0.6482 | $1.49 | +247% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.183 | $0.1868 | $0.2441 | +0.00% |
| September 2026 | $0.158 | $0.1921 | $0.2436 | +2.83% |
| October 2026 | $0.1539 | $0.1896 | $0.2454 | -1.27% |
| November 2026 | $0.1655 | $0.2063 | $0.2713 | +8.76% |
| December 2026 | $0.1724 | $0.2172 | $0.2898 | +5.29% |
Click any year to see its month-by-month PHGE forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, PHGE is projected to trade between $0.183 and $0.2898, averaging $0.1868 — a potential gain of 0% from today's $0.1868. A consolidation phase looks the most probable path here.
BiomX Inc.'s 2027 outlook centres on $0.2079, within a $0.1515 to $0.3083 range. That is up +11% on the projected 2026 average. That marks a +11% change versus current levels. Price action looks broadly range-bound.
By 2028, PHGE could reach as high as $0.3469, with a base case around $0.2192 and support toward $0.1502 — roughly +17% from $0.1868. A consolidation phase looks the most probable path here.
Expect PHGE to range from $0.1184 to $0.3029 through 2029. The $0.1822 average target implies a -2% move from current prices. That is -17% versus the projected 2028 average. Price action looks broadly range-bound.
The PHGE price prediction for 2030 points to an average of $0.1469 (low $0.0911, high $0.2543) — a potential decline of -21% on today's $0.1868. Expect choppier, lower action through this leg of the cycle.
In 2031, PHGE is projected to trade between $0.1244 and $0.3761, averaging $0.2098 — a potential gain of +12% from today's $0.1868. That is up +43% on the projected 2030 average. Price action looks broadly range-bound.
BiomX Inc.'s 2032 outlook centres on $0.255, within a $0.145 to $0.4715 range. That is up +22% on the projected 2031 average. That marks a +37% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, PHGE could reach as high as $0.4786, with a base case around $0.2518 and support toward $0.1375 — roughly +35% from $0.1868. Momentum favours further upside here.
Expect PHGE to range from $0.1331 to $0.4942 through 2034. The $0.2536 average target implies a +36% move from current prices. That is up +1% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The PHGE price prediction for 2035 points to an average of $0.2258 (low $0.114, high $0.4505) — a potential gain of +21% on today's $0.1868. Momentum favours further upside here.
In 2040, PHGE is projected to trade between $0.1456 and $0.7095, averaging $0.3235 — a potential gain of +73% from today's $0.1868. That is up +43% on the projected 2035 average. Buyers look set to stay in control over this stretch.
BiomX Inc.'s 2050 outlook centres on $0.6482, within a $0.2917 to $1.49 range. That is up +100% on the projected 2040 average. That marks a +247% change versus current levels. Momentum favours further upside here.
Investing $1,000 in PHGE today (≈ 5,353.319058 PHGE) could be worth
$3,469.96
+$2,469.96 (+247%) by 2050 · US Dollar
Based on the average projected PHGE price of $0.65 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PHGEwould be worth at today's price.
$1,000 invested in PHGE on Jul 31, 2025 (≈ 134.952769 PHGE) would be worth
$25.21
-$974.79 (-97.5%) today · 0.03× · US Dollar
Based on a PHGE entry price of $7.41 vs. today's $0.1868.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.189 | $988.36 | -1.2% |
| 1 month ago | $0.319 | $585.58 | -41.4% |
| 3 months ago | $0.79 | $236.46 | -76.4% |
| 6 months ago | $6.23 | $29.98 | -97.0% |
| 1 year ago | $7.41 | $25.21 | -97.5% |
| All time (5.0y) ago | $782.8 | $0.24 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PHGE forecast.
Our base-case forecast reaches $0.37 around 2050.
Implied market cap at $0.37: $3.99M
The multi-year forecast shows a bearish trajectory in 2030, with min $0.0921, avg $0.1487, max $0.2577 and ROI -21.3% (sentiment BEARISH). This is followed by a recovery phase in subsequent years, with 2032 avg $0.2541 (ROI 34.5%), 2033 avg $0.2521 (ROI 33.4%), and 2034 avg $0.2634 (ROI 39.4%).
In 2040 the avg price is projected at $0.3317 with ROI 75.5%, and by 2050 the avg rises to $0.6517 with ROI 244.8% and a max of $1.50. These figures point to meaningful upside potential in the long run, albeit with notable near-term risk and volatility. These are estimates, not guarantees.
Tap a question to reveal the answer.
In 2030, the forecast shows min $0.0921, avg $0.1487, max $0.2577 with ROI -21.3%. These are estimates, not guarantees.
Forecasts show a mix of outcomes: 2030 is bearish with ROI -21.3%, while 2040 and 2050 are bullish with ROIs of 75.5% and 244.8%, respectively. These are estimates, not guarantees.
Yes. The forecast's 2040 max is $0.7277, which crosses $0.70. These are estimates, not guarantees.
Current price is $0.189 and market cap is $2.04M. These are estimates, not guarantees.
2030 avg $0.1487 with ROI -21.3%; 2040 avg $0.3317 with ROI 75.5%; 2050 avg $0.6517 with ROI 244.8% (max $1.50). These are estimates, not guarantees.
BiomX Inc. Community Discussion
0Share your BiomX Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.